Deeply concerned: China on ICMR's decision to not use rapid test kits from two Chinese firms

China on Tuesday said it was "deeply concerned" over the evaluation result of the COVID-19 rapid testing kits supplied to India by two Chinese companies and subsequent decision by the Indian Council of Medical Research (ICMR) to not use the equipment, and hoped that New Delhi will resolve the issue "reasonably and properly".

The ICMR on Monday asked states and union territories to stop using the test kits procured from the Chinese companies Guangzhou Wondfo Biotech and Zhuhai Livzon Diagnostics due to "wide variations" in their performance.

"We are deeply concerned with the evaluation results and the decision made by the Indian Council of Medical Research. China attaches great importance to the quality of exported medical products," Chinese embassy Spokeperson Ji Rong said.

In a statement, she also said it is "unfair and irresponsible for certain individuals to label Chinese products as 'faulty' and look at the issues with preemptive prejudice."
The Chinese embassy spokesperson hoped that India would respect
"China's goodwill and sincerity, strengthen communication timely with relevant Chinese companies based on facts, and resolve it reasonably and properly."